High level of C-reactive protein as a predictive factor for immune-related adverse events of immune checkpoint inhibitors in non-small cell lung cancer: a retrospective study

BACKGROUND: Several risk factors for the immune-related adverse events (irAEs) during treatment with immune checkpoint inhibitors (ICIs) have been reported, of which include high levels of C-reactive protein (CRP). In this study, we aim to evaluate CRP levels before ICIs treatments as potential pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Onodera, Ren, Chiba, Shinji, Nihei, Satoru, Fujimura, Itaru, Akiyama, Masachika, Utsumi, Yu, Nagashima, Hiromi, Kudo, Kenzo, Maemondo, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482655/
https://www.ncbi.nlm.nih.gov/pubmed/37691668
http://dx.doi.org/10.21037/jtd-23-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482655/
https://www.ncbi.nlm.nih.gov/pubmed/37691668
http://dx.doi.org/10.21037/jtd-23-85

Ejemplares similares